Analysis of Hypovitaminosis D and Osteopenia/Osteoporosis in Spinal Disease Patients Who Underwent a Spinal Fusion at Illinois Neurological Institute, Peoria, IL., a Retrospective Review From November 1, 2012 to October 31, 2014 and Prospective Pilot From July 1, 2015-June 30, 2016

Bone Health is becoming of great concern in the population > 50 years old in the past several
decades. Literature review has detected a high incidence of patients with hypovitaminosis D
and back pain. Vitamin D Deficiency is in all races, age groups, and ethnic backgrounds
affecting greater than one billion people worldwide1. There is a higher incidence of Vitamin
D Deficiency noted in the northern states.

Adequate Vitamin D is essential in bone health and muscle function. It also has been reported
to have positive effects on decreasing myopathy and /or musculoskeletal pain. Vitamin D has
been shown to have a protective effect on fracture risk by providing increased bone matrix
and on fall prevention through improved muscle function. 2

Deficiency of this vitamin can lead to impaired bone mineralization and bone softening
diseases including osteomalacia and osteoporosis in adults. Osteomalacia has significant risk
factors for vertebral fractures, and spinal instrumentation failure. Low-energy fractures or
fragility fractures have been found to be more common because of an increase in life
expectancy 3. The total 25-hydroxyvitamin D (25-OH-VitD) level (the sum of 25-OH-vitamin D2
and 25-OH-vitamin D3) is the appropriate indicator of vitamin D body stores. Presently, there
is no universal consensus about a treatment cut point. Studies suggest >30 ng/mL as the
minimal concentration of 25-OH-Vit D Total is needed to avoid the adverse effects of
deficiency4. Vitamin D insufficiency is considered at <30ng/ml to 21 ng/ml and Vitamin D
Deficiency is <20 ng/ml of 25-OH-Vit D Total. Several researches have indicated increasing
Vitamin D levels >45 ng/ml will increase their immune system, bone health, lower risks of
neurological disorders and cancers. 3,4

Influential pathophysiological changes in osteoporosis include the hyperactivity of
osteoclasts compared to the need for bone remodeling or a decreased activity of osteoblasts
compared to the need for bone cavity repair or laying down new bone.5 Osteoporosis has become
synonymous with decreased bone mineral density (BMD). Bone Marrow Density scans (DXA) allows
accurate diagnosis of osteoporosis, estimation of fracture risk, and monitoring of patients
undergoing treatment.5 In postmenopausal women and men age 50 years and older, the WHO
diagnostic T-score criteria categorizes a normal DXA scan of <1.0 or above, low bone mass or
osteopenia has a T score between <1.0 and -2.5, and osteoporosis is designated with a T-score
at -2.5 or below) are applied to BMD measurement by central DXA at the lumbar spine and
femoral neck. 5

This study was done in two parts. Part 1 was the Retrospective Study from November 1, 2012 to
October 31, 2014 and Part 2 is the Prospective pilot from July 1, 2015-June 30, 2016. We are
anticipating to raise the awareness and identify the importance of evaluating for
hypovitaminosis D and bone marrow density preoperatively in Neurosurgery Clinic for 12
months. Our goal is to show treating bone health in spinal diseased patients preoperatively
will provide optimal bone health with better long term outcomes requiring less revision
surgeries for our patients.

Research Question:

Part 1 - Retrospective Study

1. What is the prevalence of Vitamin D Deficiency in patients over 50 undergoing spinal
fusion surgery by Dr. Daniel Fassett, MD, MBA, Neurosurgeon?

Part 2- Prospective Study (screening period July 1, 2015-June 30, 2016)

1. What is the prevalence of Vitamin D Deficiency in patients over 50 undergoing spinal
fusion surgery by Dr. Daniel Fassett, MD, MBA, Neurosurgeon?

2. Do patients with Hypovitaminosis D maintain therapeutic levels between 45 ng/ml to 75
ng/ml in approximately 3, 6, and 12 months postoperatively with supplements of Vitamin
D3?

3. What are the incidences of osteopenia and osteoporosis in elective spinal fusion
patients based on a Dexascans in patients over 50 undergoing spinal fusion surgery by
Dr. Daniel Fassett, MD, MBA, Neurosurgeon?

4. Do the patients' demographic information, such as age, sex, BMI, and family history
influence the outcome measures (Vitamin D deficiency, Osteopenia, and Osteoporosis)?

(Part 1, Retrospective Study)

Inclusion Criteria:

1. 50 years old or older.

2. Patients with any form of spinal fusion surgery performed by Dr. Daniel Fassett, MD,
MBA, Neurosurgeon at OSF-INI from November 1, 2012 to October 31, 2014.

Exclusion Criteria:

3. Subjects diagnosed with chronic renal disease Stage IV or V, metastatic spinal
disease, bariatric surgery, malabsorption syndrome, seizure medication and chronic
steroid use greater than 3 months at time of surgery.

(Part 2, Observational Study)

(Screening period July 1, 2015-June 30, 2016)

Inclusion Criteria:

1. 50 years old or older.

2. Serum Vitamin D level checked prior to or at surgery.

3. BMD exam performed anytime within 2 years prior to surgery.

4. Patients with any form of spinal fusion cervical, thoracic, lumbar, surgery performed
by Dr. Daniel Fassett, MD, MBA, Neurosurgeon at OSF-INI from July 1, 2015 to May 31,
2016.

Exclusion Criteria:

5. Subjects diagnosed with:

- Chronic Renal Disease with a GFR < 45 at Stage IV

- Metastatic Spinal Disease

- Bariatric surgery

- Seizure medication

- Chronic steroid use greater than 3 months at time of surgery.